Neurostimulation Devices Market: Global Industry Trends, Growth & Forecast

The Neurostimulation Devices Market is witnessing strong growth as healthcare providers increasingly adopt advanced technologies for managing neurological disorders and chronic conditions.

According to Market Research Future, the global market was valued at USD 9.98 billion in 2025 and is projected to reach USD 29.72 billion by 2035, expanding at a CAGR of 11.50% during 2026–2035.

Neurostimulation devices are used across a range of applications, including chronic pain management, Parkinson's disease, epilepsy, depression, movement disorders, and other neurological conditions. The market includes implantable and external devices, with implantable devices currently representing the larger segment.

Technological advancements are significantly influencing the industry. Closed-loop stimulation systems, artificial intelligence, improved sensing capabilities, and more precise stimulation technologies are helping enhance treatment outcomes and expand clinical applications.

North America currently represents the largest regional market, while Asia-Pacific is expected to experience the fastest growth during the forecast period. Increasing neurological disease prevalence, improved healthcare infrastructure, and expanding access to neuromodulation therapies are expected to support continued market expansion.